It was confirmed that some of the signaling pathways regulated by multiple disease combinations (COVID-19, RA, AS, GA) could theoretically be used as therapeutic pathways for COVID-19, such as TNF signaling pathway and IL-17 signaling pathway are closely related to viral infection and inflammatory response (Figures 4F,H). The gene discussed is IL17A; the disease is COVID-19.